FrancophonIA/ELRC3.0 huggingface dataset:
English: Tacforius contains lactose
Danish: Tacforius indeholder lactose
English: Cases of BK virus associated nephropathy, as well as cases of JC virus associated progressive multifocal leukoencephalopathy (PML), have been reported in patients treated with immunosuppressants, including tacrolimus prolonged-release capsules.
Danish: Tilfælde af BK-virus associeret nefropati og JC-virus associeret progressiv multifokal leukoencephalopati (PML) er rapporteret hos patienter, der har fået behandling med immunsuppressorer, herunder depotkaplser med tacrolimus.
English: Tacforius prolonged-release capsules and tacrolimus immediate release capsules are not interchangeable.
Danish: Tacforius depotkapsler og tacrolimus kapsler, der virker umiddelbart, kan ikke udskiftes med hinanden.
English: Both the rate and extent of absorption of tacrolimus prolonged-release capsules were reduced when administered with food.
Danish: Både hastighed og absorptionsmængden af tacrolimus depotkapsler blev reduceret ved indgift sammen med mad.
English: In man, the disposition of tacrolimus after intravenous infusion may be described as biphasic.
Danish: Hos mennesker kan tacrolimus farmakokinetik efter intravenøs infusion bedst beskrives som tofaset.
English: Herbal preparations containing St. John's Wort (Hypericum perforatum) or other herbal preparations should be avoided when taking tacrolimus due to the risk of interactions that lead to either a decrease in blood concentrations of tacrolimus and reduced clinical effect of tacrolimus, or an increase in blood concentrations of tacrolimus and risk of tacrolimus toxicity (see section 4.5).
Danish: Naturlægemidler, der indeholder perikon (Hypericum perforatum), eller anden naturmedicin bør undgås ved behandling med tacrolimus pga. risikoen for interaktioner, som kan medføre enten et fald i blodkoncentrationen af tacrolimus og reduceret terapeutisk effekt af tacrolimus eller en stigning i blodkoncentrationen af tacrolimus og risiko for tacrolimustoksicitet (se pkt.
English: Benign and malignant tumours have been reported following Tacforius treatment.
Danish: Der er set godartede og ondartede svulster efter behandling med Tacforius.
English: The treatment difference (tacrolimus prolonged-release capsules - tacrolimus immediate release capsules) was 3.8% (95% confidence interval [-2.1%, 9.6%]).
Danish: Behandlingsforskellen (tacrolimus depotkapsler - tacrolimus kapsler med umiddelbar udløsning) var 3,8 % (95 % konfidensinterval [-2,1 %, 9,6 %]).
English: The incidence of efficacy failure at 12 months (defined as death, graft loss, biopsy-confirmed acute rejection, or lost to followup) was 14.0% in the tacrolimus prolonged-release capsules group (N=214), 15.1% in the tacrolimus immediate release capsules group (N=212) and 17.0% in the ciclosporin group (N=212).
Danish: Hyppigheden af manglende virkning på kliniske endepunkter ved 12 måneder (defineret ved død, tab af transplantat, biopsibekræftet akut afstødning eller ingen opfølgning) var 14,0 % i gruppen med tacrolimus depotkapsler (N=214), 15,1 % i gruppen med tacrolimus kapsler med umiddelbar udløsning (N=212) og 17,0 % i ciclosporingruppen (N=212).
English: Tacforius 5 mg capsules contain ponceau 4R.
Danish: Tacforius 5 mg kapsler indeholder ponceau 4R.
English: The relationship between tacrolimus trough levels (C24) and systemic exposure (AUC0-24) is similar between the two formulations of tacrolimus prolonged-release capsules and tacrolimus immediate release capsules.
Danish: Forholdet mellem tacrolimusniveauerne (C24) og systematisk eksponering (AUC0-24) er sammenligneligt for de to formuleringer med depotkapsler med tacrolimus og tacrolimus kapsler med umiddelbar udløsning.
English: Blood trough levels of tacrolimus should also be closely monitored following conversion from tacrolimus immediate release capsules to Tacforius, dose adjustments, changes in the immunosuppressive regimen, or co-administration of substances which may alter tacrolimus whole blood concentrations (see section 4.5).
Danish: Dalværdierne for tacrolimuskoncentrationerne i blodet bør også monitoreres nøje i følgende tilfælde: ved overgang fra tacrolimus kapsler med umiddelbar udløsning til Tacforius, ved dosisjusteringer, ved ændring i den immunsuppressive behandling samt ved administration sammen med stoffer, som kan ændre koncentrationen af tacrolimus i fuldblod (se pkt.
English: 0.5 mg, 1 mg, 3 mg Contains lactose.
Danish: 0,5 mg, 1 mg, 3 mg
English: Tacforius is a once-a-day oral formulation of tacrolimus.
Danish: Tacforius er en oral formulering af tacrolimus, som skal tages en gang daglig.
English: In the systemic circulation, tacrolimus binds strongly to erythrocytes resulting in an approximate 20:1 distribution ratio of whole blood/plasma concentrations.
Danish: Tacrolimus er kraftigt bundet til erytrocytterne, således at fuldblod/plasmakvotienten er ca. 20:1 i det systemiske kredsløb.
English: Tacforius 5 mg prolonged-release hard capsules: red iron oxide (E172), yellow iron oxide (E172), titanium dioxide (E171), black iron oxide (E172), ponceau 4R (E124), gelatin.
Danish: Tacforius 5 mg hårde depotkapsler: rød jernoxid (E172), gul jernoxid (E172), titandioxid (E171), sort jernoxid (E172), ponceau 4R (E124), gelatine.
English: Shellac, propylene glycol, black iron oxide (E172), potassium hydroxide.
Danish: Shellac, propylenglycol, sort jernoxid (E172), kaliumhydroxid.
English: As tacrolimus is a substance with low clearance, following adjustments to the Tacforius dose regimen it may take several days before the targeted steady state is achieved.
Danish: Da tacrolimus er et lægemiddelstof med lav clearance, kan det tage adskillige dage efter en dosisjustering af Tacforius, før den ønskede steady state er opnået.
English: How to store Tacforius 6.
Danish: Sådan skal du tage Tacforius 4.
English: Your doctor also needs to know if you are taking potassium supplements or certain diuretics used for heart failure, hypertension and kidney disease, (e.g. amiloride, triamterene, or spironolactone), nonsteroidal anti-inflammatory medicines (NSAIDs, e.g. ibuprofen) used for fever, inflammation and pain, anticoagulants (blood thinners), or oral medicines for diabetes, while you take Tacforius.
Danish: Lægen skal også vide, om du tager kaliumtilskud eller særlig vanddrivende medicin, som bruges ved hjertesvigt, hypertension og nyresygdom (f.eks. amilorid, triamteren eller spironolacton), non-steroide anti-inflammatoriske midler (NSAID, f.eks. ibuprofen), som bruges ved feber, betændelsestilstande og smerter, blodfortyndende medicin (antikoagulantia) eller oral medicin mod diabetes (sukkersyge), mens du tager Tacforius.
English: Other factors observed to increase the risk of these clinical conditions included pre-existing heart disease, corticosteroid usage, hypertension, renal or hepatic dysfunction, infections, fluid overload, and oedema.
Danish: Andre faktorer, der kan øge risikoen for disse kliniske tilstande, er tidligere hjertelidelse, behandling med kortikosteroider, hypertension, nedsat nyre- eller leverfunktion, infektion, væskeretention og ødem.
English: Tacforius therapy should commence at a dose of 0.10 - 0.20 mg/kg/day administered once daily in the morning.
Danish: Behandling med Tacforius bør påbegyndes med en dosis på 0,10 - 0,20 mg/kg/dag administreret én gang daglig om morgenen.
English: The initial oral per protocol dose of tacrolimus was 0.2 mg/kg/day with subsequent dose adjustments to target trough levels of 8 to 15 ng/ml by Day 5 and 5 to 10 ng/ml after Month 6.
Danish: Den initiale orale per protokol dosis af tacrolimus var 0,2 mg/kg/dag med følgende dosisjustering for at opnå dalkoncentrationer på 8-15 ng/ml på 5. dagen og 5-10 ng/ml efter 6. måned.
English: Limited data from organ transplant recipients show no evidence of an increased risk of adverse reactions on the course and outcome of pregnancy under tacrolimus treatment compared with other immunosuppressive medicinal products.
Danish: Begrænsede data fra organtransplanterede recipienter, der sammenligner tacrolimus med andre immunsuppressive midler, viser ingen tegn på øget risiko for bivirkninger på graviditetsforløbet eller resultatet heraf ved behandling med tacrolimus.
English: Results from clinical trials performed with once-daily tacrolimus prolonged-release capsules
Danish: Resultater fra kliniske studier udført med tacrolimus depotkapsler en gang daglig Levertransplantation
English: The efficacy and safety of tacrolimus immediate release capsules, ciclosporin and tacrolimus prolonged-release capsules, all in combination with basiliximab antibody induction, MMF and corticosteroids, was compared in 638 de novo kidney transplant recipients.
Danish: Virkningen og sikkerheden af tacrolimus kapsler med umiddelbar udløsning, ciclosporin og tacrolimus depotkapsler, alle i kombination med basiliximab antistofinduktion, MMF og kortikosteroider, blev sammenlignet i 638 de novo nyretransplanterede patienter.
English: Tacrolimus immediate release capsules (e.g, Tacni) and Tacforius prolonged-release capsules both contain the active substance, tacrolimus.
Danish: Almindelige tacrolimus kapsler, der virker umiddelbart (f.eks. Tacniteva), og Tacforius depotkapsler indeholder begge det aktive stof tacrolimus.
English: Clinical efficacy and safety of tacrolimus immediate release capsules bid in primary organ transplantation
Danish: Klinisk virkning og sikkerhed for tacrolimus kapsler med umiddelbar udløsning administreret to gange daglig ved primær organtransplantation
English: Tacforius therapy should commence at a dose of 0.20 - 0.30 mg/kg/day administered once daily in the morning.
Danish: Behandling med Tacforius bør påbegyndes med en dosis på 0,20 - 0,30 mg/kg/dag administreret én gang daglig om morgenen.
English: encephalopathy, central nervous system haemorrhages and cerebrovascular accidents, coma, speech and language abnormalities, paralysis and paresis, amnesia rare:
Danish: encefalopati, blødning i centralnervesystemet og cerebrovaskulære anfald, koma, tale- og sprogforstyrrelser, paralyse og pareser, amnesi
English: 12-month graft survival was 85.3% for tacrolimus prolonged-release capsules and 85.6% for tacrolimus immediate release capsules.
Danish: Transplantatoverlevelsen efter 12 måneder var 85,3 % for tacrolimus depotkapsler og 85,6 % for tacrolimus kapsler med umiddelbar udløsning.
English: Supplied in blisters or perforated unit-dose blisters containing 10 capsules within a protective foil pouch, including a desiccant.
Danish: Leveres i blistere eller perforerede enkeltdosisblistere med 10 kapsler i en beskyttende foliepose med et tørremiddel.
English: Conversion of tacrolimus immediate release capsules-treated patients to Tacforius
Danish: Omstilling af patienter behandlet med tacrolimuskapsler med umiddelbar udløsning til Tacforius
English: The relationship between tacrolimus trough levels (C24) and systemic exposure (AUC0-24) for tacrolimus prolonged-release capsules is similar to that of tacrolimus immediate release capsules.
Danish: Forholdet mellem dalværdierne (C24) og systemisk eksponering (AUC0-24) af depotkapsler med tacrolimus er sammenligneligt med det for tacrolimus kapsler med umiddelbar udløsning.
English: The event rate for biopsy-confirmed acute rejection within the first 24 weeks after transplantation was 18.6% in the tacrolimus prolonged-release capsules group (N=331) and 14.9% in the tacrolimus immediate release capsules group (N=336).
Danish: Hyppigheden for biopsibekræftet akut afstødning inden for de første 24 uger efter transplantationen var 18,6 % i gruppen med tacrolimus depotkapsler (N=331) og 14,9 % i gruppen med tacrolimus kapsler med umiddelbar udløsning (N=336).
English: A variety of innovations, such as techniques for early detection of Epstein-Barr (EBV) and CMV infections, bone marrow augmentation, the adjunct use of the interleukin - 2 antagonist daclizumab, lower initial tacrolimus doses with target trough levels of 10 to 15 ng/ml, and most recently allograft irradiation were considered to have contributed to improved results in this indication over time.
Danish: Forskellige innovationer har bidraget til at forbedre resultaterne ved denne indikation: teknik til tidlig diagnose af Epstein-Bar (EBV) og CMV-infektioner, knoglemarvsforøgelse, samtidig brug af interleukin 2-antagonisten daclizumab, lavere initiale doser af tacrolimus med dalkoncentrationer på 10-15 ng/ml og senest bestråling af allotransplantat.
English: 12 - month graft survival was 96.7% for tacrolimus prolonged-release capsules, 92.9% for tacrolimus immediate release capsules and 95.7% for ciclosporin.
Danish: Transplantatoverlevelsen efter 12 måneder var 96,7 % for tacrolimus depotkapsler, 92,9 % for tacrolimus kapsler med umiddelbar udløsning og 95,7 % for ciclosporin.
English: Tacrolimus is a known CYP3A4 inhibitor; thus concomitant use of tacrolimus with medicinal products known to be metabolised by CYP3A4 may affect the metabolism of such medicinal products.
Danish: Da tacrolimus er en kendt CYP3A4-hæmmer vil samtidig brug af tacrolimus påvirke metabolismen af lægemidler, der metaboliseres via CYP3A4.
English: The efficacy and safety of tacrolimus prolonged-release capsules and tacrolimus immediate release capsules, both in combination with corticosteroids, was compared in 471 de novo liver transplant recipients.
Danish: Virkningen og sikkerheden af tacrolimus depotkapsler og tacrolimus kapsler med umiddelbar udløsning, begge i kombination med kortikosteroider, blev sammenlignet i 471 de novo levertransplanterede patienter.
English: Absorption In man tacrolimus has been shown to be able to be absorbed throughout the gastrointestinal tract.
Danish: Hos mennesker er det vist, at tacrolimus kan absorberes i hele mave-tarm-kanalen.
English: CYP3A4 inducers potentially leading to decreased tacrolimus blood levels
Danish: CYP3A4-inducere som potentielt kan nedsætte tacrolimus' blodkoncentrationer
English: Tacforius 3 mg / 5 mg prolonged-release hard capsules 30 months
Danish: Tacforius 3 mg/5 mg depotkapsler, hårde 30 måneder
English: Therefore, you should not breast-feed whilst using Tacforius.
Danish: Derfor bør du ikke amme, når du tager Tacforius.
English: The event rate of biopsy confirmed acute rejection within the first 24 weeks after transplantation was 32.6% in the tacrolimus prolonged-release capsules group (N=237) and 29.3% in the tacrolimus immediate release capsules group (N=234).
Danish: Hyppigheden af biopsibekræftet akut afstødning inden for de første 24 uger efter transplantation var 32,6 % i gruppen med tacrolimus depotkapsler (N=237) og 29,3 % i gruppen med tacrolimus kapsler med umiddelbar udløsning (N=234).
English: The efficacy and safety of tacrolimus prolonged-release capsules and tacrolimus immediate release capsules, both in combination with mycophenolate mofetil (MMF) and corticosteroids, was compared in 667 de novo kidney transplant recipients.
Danish: Virkningen og sikkerheden af tacrolimus depotkapsler og tacrolimus kapsler med umiddelbar udløsning, begge i kombination med mycophenolatmofetil (MMF) og kortikosteroider, blev sammenlignet i 667 de novo nyretransplanterede patienter.
English: - if you have or have had liver problems - if you have diarrhoea for more than one day - if you feel strong abdominal pain accompanied or not with other symptoms, such as chills,
Danish: hvis du eller har haft leverproblemer hvis du har diarré i mere end én dag hvis du får stærke mavesmerter med eller uden andre symptomer, som kulderystelser, feber, kvalme eller opkastning hvis du får en ændring i hjerterytmen (kaldet “QT-forlængelse”).
English: Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.
Danish: Brug af anden medicin sammen med Tacforius Fortæl det altid til lægen eller apotekspersonalet, hvis du tager anden medicin, for nylig har taget anden medicin eller planlægger at tage anden medicin.
English: Careful and frequent monitoring of tacrolimus trough levels is recommended in the first two weeks post-transplant with Tacforius to ensure adequate drug exposure in the immediate post-transplant period.
Danish: For at sikre en fyldestgørende eksponering i begyndelsen af den posttransplanterede periode anbefales det at overvåge tacrolimus' dalværdier omhyggeligt og hyppigt de første to uger med Tacforius efter transplantationen.
English: Tacforius 0.5 mg / 1 mg / 3 mg prolonged-release hard capsules: red iron oxide (E172), yellow iron oxide (E172), titanium dioxide (E171), gelatin.
Danish: Tacforius 0,5 mg/1 mg/3 mg hårde depotkapsler: rød jernoxid (E172), gul jernoxid (E172), titandioxid (E171), gelatine.
English: As tacrolimus is a substance with low clearance, adjustments to the Tacforius dose regimen may take several days before steady state is achieved.
Danish: Da tacrolimus er et stof med lav clearance, kan det tage flere dage, inden steady state opnås efter justering af dosis.
English: 5 mg Contains lactose and ponceau 4R.
Danish: Indeholder lactose og ponceau 4R.
English: Clinically the following substances have been shown to increase tacrolimus blood levels: Strong interactions have been observed with antifungal agents such as ketoconazole, fluconazole, itraconazole, voriconazole and isavuconazole, the macrolide antibiotic erythromycin, HIV protease inhibitors (e.g. ritonavir, nelfinavir, saquinavir) or HCV protease inhibitors (e.g. telaprevir, boceprevir, and the combination of ombitasvir and paritaprevir with ritonavir, when used with and without dasabuvir), the pharmacokinetic enhancer cobicistat, and the tyrosine kinase inhibitors nilotinib and imatinib.
Danish: Der er set kraftige interaktioner med svampemidler som ketoconazol, fluconazol, itraconazol, voriconazol og isavuconazol, det macrolide antibiotikum erythromycin, hiv-proteasehæmmere (f.eks. ritonavir, nelfinavir, saquinavir) eller HCV-protease-hæmmere (f.eks. telaprevir, boceprevir og en kombination af ombitasvir og paritaprevir sammen med ritonavir, når det anvendes med og uden dasabuvir), den farmakokinetiske forstærker cobicistat og tyrosinkinasehæmmerne nilotinib og imatinib.
English: 12-month graft survival was 91.5% for tacrolimus prolonged-release capsules and 92.8% for tacrolimus immediate release capsules.
Danish: Transplantatoverlevelsen efter 12 måneder var 91,5 % for tacrolimus depotkapsler og 92,8 % for tacrolimus kapsler med umiddelbar udløsning.
English: Each capsule contains 322.35 mg lactose.
Danish: Hjælpestof, som behandleren skal være opmærksom på Hver kapsel indeholder 322,35 mg lactose.
English: Propylene glycol Black iron oxide (E172) Potassium hydroxide
Danish: Propylenglycol Sort jernoxid (E 172) Kaliumhydroxid
English: The 12 - month patient survival rates were 98.6% for tacrolimus prolonged-release capsules, 95.7% for tacrolimus immediate release capsules and 97.6% for ciclosporin; in the tacrolimus prolonged-release capsules arm 3 patients died (all male), in the tacrolimus immediate release capsules arm 10 patients died (3 female, 7 male) and in the ciclosporin arm 6 patients died (3 female, 3 male).
Danish: Overlevelsesraten efter 12 måneder var 98,6 % for tacrolimus depotkapsler, 95,7 % for tacrolimus kapsler med umiddelbar udløsning og 97,6 % for ciclosporin; i armen med tacrolimus depotkapsler døde 3 patienter (alle mænd), i armen med tacrolimus kapsler med umiddelbar udløsning døde 10 patienter (3 kvinder, 7 mænd), og i ciclosporingruppen døde 6 patienter (3 kvinder, 3 mænd).
English: Tacrolimus is widely metabolised in the liver, primarily by the cytochrome P450 - 3A4.
Danish: Tacrolimus metaboliseres i udstrakt grad i leveren, primært af CYP3A4.
English: Tacforius capsules contain lactose.
Danish: Tacforiuskapsler indeholder lactose.
English: bile duct disorders, hepatocellular damage and hepatitis, cholestasis and jaundice rare:
Danish: galdegangssygdomme, skade på leverceller og hepatitis, colestase og gulsot
English: How to take Tacforius
Danish: Sådan skal du tage Tacforius
English: The 12-month patient survival rates were 96.9% for tacrolimus prolonged-release capsules and 97.5% for tacrolimus immediate release capsules; in the tacrolimus prolonged-release capsules arm 10 patients died (3 female, 7 male) and in the tacrolimus immediate release capsules arm 8 patients died (3 female, 5 male).
Danish: Overlevelsesraten efter 12 måneder var 96,9 % for tacrolimus depotkapsler og 97,5 % for tacrolimus kapsler med umiddelbar udløsning; i armen med tacrolimus depotkapsler døde 10 patienter (3 kvinder, 7 mænd), og i armen med tacrolimus kapsler med umiddelbar udløsning døde 8 patienter (3 kvinder, 5 mænd).
English: What you need to know before you take Tacforius Do not take Tacforius
Danish: Det skal du vide, før du begynder at tage Tacforius
English: Each capsule contains 53.725 mg lactose.
Danish: Hjælpestof, som behandleren skal være opmærksom på Hver kapsel indeholder 53,725 mg lactose.
English: Each capsule contains 107.45 mg lactose.
Danish: Hjælpestof, som behandleren skal være opmærksom på Hver kapsel indeholder 107,45 mg lactose.
English: - the corticosteroids prednisolone and methylprednisolone, belonging to the class of corticosteroids used to treat inflammations or suppress the immune system (e.g. in transplant rejection) - nefazodone, used to treat depression - Herbal preparations containing St. John's Wort (Hypericum perforatum) or extracts of Schisandra sphenanthera.
Danish: lægemidler kendt som ”statiner” til behandling af forhøjet kolesterol og triglycerider fenytoin eller fenobarbital, til behandling af epilepsi kortikosteroiderne prednisolon og methylprednisolon, der anvendes til behandling af betændelsestilstande eller til at undertrykke immunsystemet (f.eks. ved afstødning af organ efter transplantation) nefazodon til behandling af depression naturmedicin, der indeholder perikon (Hypericum perforatum) eller ekstrakt af Schisandra sphenanthera.
English: CYP3A4 inhibitors potentially leading to increased tacrolimus blood levels
Danish: CYP3A4-hæmmere som potentielt kan øge tacrolimus' blodkoncentrationer
English: Tacrolimus was started as continuous intravenous infusion at a dose of 0.05 mg/kg/day and oral tacrolimus was administered at a dose of 0.1 to 0.3 mg/kg/day with subsequent dose adjustments to target trough levels of 12 to 15 ng/ml.
Danish: Tacrolimus startede som kontinuerlig intravenøs infusion med doser på 0,05 mg/kg/dag, hvorefter oral tacrolimus blev administreret i doser på 0,1-0,3 mg/kg/dag med følgende dosisjustering for at nå dalkoncentrationer på 12-15 ng/ml.
English: Tacforius 0.5 mg / 3 mg / 5 mg prolonged-release hard capsules Pack sizes: 30, 50 and 100 prolonged-release hard capsules in blisters or 30x1, 50x1 and 100x1 prolonged-release hard capsules in perforated unit-dose blisters.
Danish: Tacforius 0,5 mg/3 mg/5 mg depotkapsler, hårde Pakningsstørrelser: 30, 50 og 100 depotkapsler, hårde, i blisterkort eller 30x1, 50x1 og 100x1 depotkapsler, hårde, i perforeret enkeltdosisblisterkort.
English: gastrointestinal signs and symptoms, vomiting, gastrointestinal and abdominal pains, gastrointestinal inflammatory conditions, gastrointestinal haemorrhages, gastrointestinal ulceration and perforation, ascites, stomatitis and ulceration, constipation, dyspeptic signs and symptoms, flatulence, bloating and distension, loose stools uncommon:
Danish: symptomer fra mave-tarmkanalen, opkastning, abdominale og gastrointestinale smerter, inflammatoriske lidelser i mave-tarm-kanalen, blødning i mave-tarm-kanalen, ulceration og perforation i mave-tarm-kanalen, ascites, ulcerøs stomatitis, obstipation, dyspepsi, flatulens, oppustethed, tynd afføring
English: - Cyst formation in your pancreas - Problems with blood flow in the liver - Serious illness with blistering of skin, mouth, eyes and genitals; increased hairiness - Thirst, fall, feeling of tightness in your chest, decreased mobility, ulcer
Danish: Alvorlig sygdom med blærer i huden, munden, øjnene og kønsorganerne, øget behåring Tørst, øget tendens til at falde, trykken for brystet, nedsat bevægelighed, sår
English: Tacforius 0.5 mg / 1 mg / 3 mg prolonged-release hard capsules Red iron oxide (E172)
Danish: Tacforius 0,5 mg/1 mg/3 mg depotkapsler, hårde Rød jernoxid (E 172)
English: deafness neurosensory very rare:
Danish: Nervesystemet Meget almindelig: